Catheter Precision Stock Suddenly Takes Off: Why VTAK Is on Traders’ Radar Today
Catheter Precision soared 34.5% premarket after registering 68.1 million shares for resale—25 times shares outstanding—amid new heart-failure patents, a Flyte sports partnership, and warnings of “substantial doubt” about its ability to continue as a going concern due to a $441,000 cash balance and $18.5 million deficit.